BioPharmSignal logoBioPharmSignal

Biotech News

embecta to Report Fiscal Second Quarter Financial Results

Embecta (EMBC)EmbectaEarnings

PARSIPPANY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal second quarter 2026 financial

Open original release

Related news

EMBCEmbecta2026-05-05 10:30 EST

Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results

EMBCEmbecta2026-01-22 22:00 EST

embecta to Report Fiscal First Quarter Financial Results

VKTXViking Therapeutics2026-07-22 20:05 EST

Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026

MNKDMannKind2026-04-29 20:01 EST

MannKind to Report First Quarter 2026 Financial Results on May 6, 2026

CVRXCVRx2026-04-27 20:30 EST

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

MNKDMannKind2026-02-18 14:00 EST

MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

CVRXCVRx2026-01-29 21:10 EST

CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026

SYBXSynlogic2024-08-08 11:00 EST

Synlogic Reports Second Quarter 2024 Financial Results

ALGSAligos Therapeutics2026-05-07 20:06 EST

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results

MISTMilestone Pharmaceuticals Inc.2026-05-06 12:00 EST

Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026

View all latest news

Embecta

Embecta is a diabetes care company built around insulin delivery devices and related consumables. Its story is less about broad biotech innovation and more about recurring demand in chronic disease management.

Recent company news

EMBCEmbecta2026-06-01 21:00 EST

embecta to Participate in Investor Events

EMBCEmbecta2026-05-15 13:00 EST

embecta Completes Acquisition of Owen Mumford Holdings Limited

EMBCEmbecta2026-05-08 13:00 EST

embecta to Participate at the 2026 BofA Securities Global Health Care Conference

EMBCEmbecta2026-05-05 10:30 EST

Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results

EMBCEmbecta2026-05-05 10:30 EST

embecta Announces Quarterly Cash Dividend

Stock data

Close
3.44 USD
Market cap
207.05M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States